Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114667346B reveals a novel EanB mutant for efficient ergothioneine production. Discover cost-effective, scalable enzymatic synthesis solutions for global supply chains.
Patent CN117887739A reveals enzymatic route for moxifloxacin intermediate offering cost reduction and high purity for pharmaceutical manufacturing supply chains.
Patent CN112941116A details a novel enzymatic route for alpha-ketoglutarate calcium, offering superior purity and cost reduction in pharmaceutical manufacturing.
Patent CN120757482A reveals manganese catalysis for high-purity indole carbazole intermediates ensuring cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Patent CN109293488B reveals a molten salt method for 5-chloroindanone, offering higher yields and safer processing for agrochemical and pharmaceutical intermediates.
Patent CN108002966B details a safe Ni(II) catalyzed cross-coupling method. Discover cost-effective manufacturing solutions for high-purity pharmaceutical intermediates.
Advanced solid chiral catalyst process for florfenicol intermediates. Enhances yield, reduces environmental impact, and ensures supply chain reliability for veterinary drug manufacturers.
Patent CN114805395B details a continuous synthesis of ACB-7 with high yield, avoiding toxic reagents. Ideal for reliable pharmaceutical intermediates supply chains.
Patent CN102010381B details a low-toxicity valsartan synthesis using TMSA and TBAF. Discover cost-effective, scalable API intermediate manufacturing solutions.
Patent CN114657164B reveals a novel enzymatic route for L-glufosinate, offering superior purity and cost efficiency for agrochemical intermediate supply chains.
Patent CN103003257B details a one-step L-carnitine synthesis. Offers high purity, cost reduction, and supply chain reliability for pharmaceutical intermediates.
Patent CN102786436A details a novel ionic liquid catalyzed esterification for cyanoacetates, offering superior purity, recyclability, and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN1210248C reveals a superior Group 4 catalyzed esterification process offering high purity cyclopropane intermediates with reduced side reactions and enhanced supply chain reliability for global manufacturers.
Patent CN112724111B reveals a novel KF/Al2O3 catalyzed route for ODPA, offering higher yields and reduced waste for electronic chemical manufacturing.
Patent CN109824491B reveals a green synthesis route for 2,3,4,4'-tetrahydroxybenzophenone using magnetic ionic liquids, offering high purity and easy catalyst recovery.
Patent CN101357908B details a green one-pot method converting TPPO waste into high-purity Dibenzothiazole Disulfide and Triphenylphosphine, offering significant cost reduction.
Novel ionic liquid synthesis route for high-purity indole carbazole derivatives. Offers significant cost reduction and scalable supply chain solutions for pharmaceutical manufacturing partners globally.
Patent CN111606962A details a safe levonorgestrel synthesis avoiding lithium ammonia, offering high purity and yield for reliable API intermediate supply chains.
Patent CN104498510A enables enzymatic synthesis of atorvastatin side chain with superior stereoselectivity and scalable fermentation processes for global supply chains.
Novel alkali-modified mesoporous molecular sieve catalyst replaces NaOH for high-yield, scalable Pemetrexed Disodium production with superior purity.